Canada: A "Green Rush" For Debt Financing?

Canadian cannabis policy announcements over the past year have spurred investment in licensed cannabis producers and dealers ("Licensed Producers"), resulting in one of Canada's newest growth industries. Deloitte projects the potential size of a legal, recreational retail cannabis market at $9 billion.2 Equity investors have responded with what is becoming known as the "green rush," with medical marijuana companies raising more than $466 million in Canadian capital markets in 2016.3

While it is high times for equity financing, there is far less buzz for debt financing of Licensed Producers. Indeed, the Chief Executive Officer of one leading Toronto Stock Exchange-listed Licensed Producer has gone on record to say that "debt financing is the principal absent business instrument for the [regulated cannabis] sector."4

What is holding lenders back from a "green rush" of debt financing?

Setting aside potential reputational risk associated with cannabis, there are other risks involved with lending to Licensed Producers:

  • Risks of Lending to Non-Compliant Borrowers: Since cannabis is currently a controlled substance,5 a borrower's non-compliance with the Access to Cannabis for Medical Purposes Regulations6 could create major risks for a lender. Under the Regulations, in order for a Licensed Producer to be legally permitted to cultivate, produce and/or sell marijuana, it must have received the requisite licence(s) from Health Canada. Noncompliance with such regulations can result in the revocation of a licence and has the potential to attract criminal liability/charges for the Licensed Producer. Actual or suspected non-compliance could therefore lead to a Licensed Producer's assets being forfeited to the Crown under civil forfeiture legislation;7 potentially resulting in a significant loss of a lender's collateral.
  • Difficulties Ascertaining Compliance: Production, shipping, packaging, record-keeping, client eligibility, product security and export of marijuana are all extensively regulated on an ongoing basis by Health Canada under complex rules. Lenders should carefully scrutinize the business operations and practices of a potential Licenced Producer. If credit facilities are provided, the lender should ensure that the borrower provides the appropriate monitoring compliance certificates (perhaps on a more frequent basis than in other industries) and that the lender is immediately provided with full details of any Health Canada concerns with respect to the borrower.
  • Inability to Collateralize Licences: In some industries where licences are scarce (as is currently the case in the cannabis industry), licences are often a borrower's most valuable asset. However, only transferable and relatively stable licences are useful collateral. Currently there is no statutory or policy guidance on the transferability of Health Canada issued marijuana licences. Whether or not a Health Canada issued licence can be safely collateralized is an issue that lenders should be mindful of, as there is ministerial discretion to suspend such licences without notice8 and it is not clear whether such licences constitute "property" over which a valid security interest can attach.9
  • Difficult Inventory Enforcement: When the inventory is cannabis, lenders are in the sticky situation of having a security interest in collateral that they are not legally permitted to possess or resell. Only a Licenced Producer is permitted to possess and resell cannabis and, in order to do so, the "senior person in charge," "responsible persons in charge" and other persons must themselves hold valid security clearances and authorizations from Health Canada in connection with the licence. As such, if a lender seeks to enforce and the borrower's employees with security clearances leave the business, successful liquidation would be jeopardized. A receiver would need to retain persons with the appropriate clearances, such as another Licensed Producer or perhaps certain of their staff, in order to deal with the regulated collateral.
  • Court Involvement: In a security realization scenario involving cannabis collateral, it is unlikely that Health Canada would take a passive role. To add credibility and certainty to a security enforcement situation involving cannabis collateral, a court-ordered receivership would be the most prudent course of action. A draft receivership order would likely have to be tailored to the requirements of the regulatory context, and Health Canada should be served with materials. This approach could potentially reduce the likelihood of suspension or cancellation of the Licenced Producer's Health Canada issued licence, legitimize the sale of cannabis inventory and increase the chances of recovery.
  • Few "White Knights": Although the Regulations permit resale to other Licenced Producers, the current scarcity of Licenced Producers means the number of potential purchasers is limited. Similarly, the equipment used by a Licenced Producer cultivating cannabis may be of limited value from a margining perspective, since the number of potential purchasers of this specialized collateral is low.

In light of these issues, how can lenders protect themselves? In addition to very careful pre-commitment diligence, lenders could increase their confidence by negotiating the following rights:

  1. conservative margining (particularly with respect to valuing intangibles and inventory collateral; Licenced Producers with valuable real property interests or transferable equipment would, of course, inspire greater lender confidence);
  2. periodic monitoring rights;
  3. periodic compliance reporting by the borrower;
  4. borrower to immediately provide notice to the lender of any Health Canada concern of compliance issues;
  5. borrower covenants mirroring the demands of the Regulations; and
  6. side agreements with one or more "senior person in charge," "responsible persons in charge" and other persons that hold a valid security clearance authorized and approved by Health Canada in connection with Health Canada issued licences that provide that persons will assist with and facilitate the enforcement of the lender's security in the event of a security realization scenario.10

In addition, an acknowledgment and consent from Health Canada regarding the lender's security could be requested, providing that Health Canada will cooperate with any courtappointed officer in the context of enforcement by the lender of its security, to facilitate realization or a sale to a Health Canada-approved purchaser. This process would be familiar for lenders operating in other regulated industries, such as mining or long-term care. Alternatively, a borrower could consider issuing a notice to Health Canada advising that the borrower has granted a security interest over its personal property, including cannabis inventory, to the lender, thereby putting Health Canada on notice of the lender's security interest.

In light of these challenges, it is not surprising that institutional debt capital has been largely absent from the early days of the Canadian "green rush." As policymakers contemplate future legislation, they should consider how to address the issues identified above and support the ability of secured lenders to realize on their security.

We encourage policymakers and commentators to think of debt capital as a necessary pillar of a responsible and safe cannabis legalization strategy. Property, plant and equipment improvements – the traditional domain of asset-based lending – are essential to establishing safe and compliant production and distribution facilities. Regulatory reform that stimulates debt financing could both blaze a trail for economic growth and close the trust gap for this budding industry.

Footnotes

1 A Student-at-law. The authors acknowledge the contributions of Andrew Biderman, Aaron Collins, Daniel Everall, Lorway Gosse, Donald Johnston, Jeremy Nemers and Kyle Plunkett to the various scenarios contemplated in this article.

2 A 2016 Deloitte study suggests that the Canadian retail market for regulated recreational marijuana product is between $4.9 billion and $8.7 billion, with potential upside (including spinoff effects) exceeding $22 billion. Available online at https://www2.deloitte.com/ca/en/pages/deloitte-analytics/articles/recreational-marijuana-market.html .

3 Sunny Freeman, "Why smaller banks take bigger slice of the growing medical marijuana business," Financial Post, online: January 30 2017, http://business.financialpost.com/news/fp-street/why-smaller-banks-take-bigger-slice-of-the-growing-medical-marijuana-business.

4 Bruce Linton, CEO of Canopy Growth Corporation, quoted in Eric Lam, "This Canadian Marijuana Grower is Looking for a Loan," Bloomberg, online: July 29, 2016, https:// www.bloomberg.com/news/articles/2016-07-29/pot-grower-canopy-graduates-to-stock-big-leagues-now-seeks-loan . Linton went on to comment: "if I was producing tomatoes that yielded this margin in these buildings, I'd have a lineup of debt instruments available."

5 Controlled Drugs and Substances Act, SC 1996, c 19.

6 SOR/2016-230 (the "Regulations").

7 In Ontario, the applicable legislation is the Civil Remedies Act, 2001, S.O. 2001, c. 28. Several other provinces have comparable statutes.

8 The Regulations provide wide discretion to the Health Canada to cancel permits on public safety or other grounds (s. 40(1), and provide that licences must be cancelled if the security clearances of any "responsible person in charge" lapse.

9 In several jurisdictions, non-transferable licences are defined in the relevant personal property security legislation as property over which a security interest can be taken. In others, including Ontario, this question is resolved on a notoriously uncertain common-law test, where analysis can sometimes ends up in the weeds: see Saulnier v. Royal Bank of Canada, 2008 SCC 58.

10 The consideration and structuring of such agreements would need to be considered.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Timothy Jones
 
In association with
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.